Skip to main content

Brosh, Robert

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #3,278
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
11
Records listing this PI
Award-Linked Rank
#3,278
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Brosh, Robert. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Brosh, Robert as a PI. Multi-PI records show the full award amount for context.

  • 1ZIAAG000580-04ZIAContact PI
    Functional Significance of Mutations in Helicase Genes in Patients with Juvenile Dermatomyositis and anti-MDA5 Autoantibodies
    $627K
    award amount
  • 1ZIAAG000741-23ZIAContact PI
    Roles Of DNA Helicases In Pathways Required For Maintenance Of Genomic Stability
    $387.6K
    award amount
  • 1ZIAAG000752-16ZIAContact PI
    Model Genetic Systems to Study DNA Repair
    $347.7K
    award amount
  • 1ZIAAG000581-04ZIAContact PI
    Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines
    $285K
    award amount
  • 1ZIAAG000699-06ZIAContact PI
    G-quadruplexes (G4) are potential DNA roadblocks that perturb mitochondrial replication machinery and pose a clinically relevant source of mitochondrial DNA mutation and instability
    $228K
    award amount
  • 1ZIAAG000753-16ZIAContact PI
    Fanconi Anemia Pathway
    $74.1K
    award amount
  • 1ZIAAG000726-31ZIAContact PI
    Function of RecQ helicases in genome stability
    $57K
    award amount
  • 1ZIAAG000776-02ZIAContact PI
    COVID-19 Nsp13 Helicase Analysis: Assessment of Unwinding SARS-CoV-2 Mutagenic RNA Secondary Structures and Pharmacological Modulation in a Preclinical Model
    $57K
    award amount
  • 1ZIAAG000985-02ZIAContact PI
    Investigation of Intercalated (I) Motif DNA Structure at Telomeric Cytosine-Rich Strand in Human Cells Genetically Altered for DNA Helicases
    $57K
    award amount
  • 1ZIAAG000723-16ZIAContact PI
    DNA repair dysfunction in neurodegeneration and Alzheimer's Disease
    $44.7K
    award amount

+1 more grant not shown.

Award organization

Organizations that administered FY2023 awards listing Brosh, Robert as a PI.

FY2023 award administered by National Institute On Aging ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    National Institute On Aging
  2. 2009
    $500K Cumulative Funding
  3. 2009
    $1M Cumulative Funding
  4. 2011
    $2M Cumulative Funding
  5. 2011
    Entered Top 50% Nationally
    Ranked #9943
  6. 2014
    $5M Cumulative Funding
  7. 2017
    Entered Top 25% Nationally
    Ranked #3545
  8. 2018
    $10M Cumulative Funding